23 May 2023


We're excited to present a series of engaging and informative giant cell arteritis podcasts that delve into various aspects of rheumatology. In this blog post, we will highlight three episodes that provide valuable insights and information from our Talking Rheumatology Cases, Spotlight, and Research podcasts. 

  • Podcast 1: "Non-GCA Headache" (Talking Rheumatology Cases)
    In this thought-provoking episode, the podcast "Talking Rheumatology Cases" explores the complexities surrounding non-giant cell arteritis (non-GCA) headaches. Driven by an expert panel of rheumatologists, this discussion sheds light on the diagnostic challenges faced when differentiating headaches associated with non-GCA from other types of headaches. By sharing real-life case studies, the podcast provides a comprehensive understanding of the clinical nuances involved in diagnosing and managing non-GCA headaches.
    Listen to this episode here

  • Podcast 2: "Giant Cell Arteritis" (Talking Rheumatology Spotlight)
    "Giant Cell Arteritis," the sixth episode of the podcast series "Talking Rheumatology Spotlight," takes a deep dive into this rheumatic condition. With a focus on this often-misdiagnosed and underdiagnosed disease, renowned rheumatologists provide a comprehensive overview of giant cell arteritis, its pathophysiology, clinical presentations, and management strategies. By exploring real cases and discussing the latest advancements, this episode equips listeners with the knowledge needed to identify and effectively manage this condition. 
    Listen to this episode here

  • Podcast 3: "The Long-term Use of Tocilizumab in Giant Cell Arteritis" (Talking Rheumatology Research)
    For those seeking a deeper understanding of giant cell arteritis and its treatment options, "Talking Rheumatology Research" brings you an enlightening episode on the long-term use of tocilizumab. By examining the latest scientific studies and sharing expert opinions, this podcast delves into the efficacy and safety of tocilizumab in managing giant cell arteritis over an extended period. Gain valuable insights into the potential benefits and considerations surrounding this therapy option, and stay up-to-date with the evolving landscape of rheumatology research.
    Listen to this podcast here